کد مقاله کد نشریه سال انتشار مقاله انگلیسی نسخه تمام متن
987730 935165 2012 9 صفحه PDF دانلود رایگان
عنوان انگلیسی مقاله ISI
State-Transition Modeling: A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force-3
ترجمه فارسی عنوان
مدل سازي حالت گذرا: گزارشي از Task Force-3 روش هاي خوب پژوهشی مدل سازي ISPOR-SMDM
کلمات کلیدی
مدل سازی تصمیمی ـ تحلیلی ؛ دستورالعمل ها؛ مدل مارکف؛ مدل سازی حالت گذار
موضوعات مرتبط
علوم پزشکی و سلامت پزشکی و دندانپزشکی پزشکی و دندانپزشکی (عمومی)
چکیده انگلیسی

State-transition modeling is an intuitive, flexible, and transparent approach of computer-based decision-analytic modeling including both Markov model cohort simulation and individual-based (first-order Monte Carlo) microsimulation. Conceptualizing a decision problem in terms of a set of (health) states and transitions among these states, state-transition modeling is one of the most widespread modeling techniques in clinical decision analysis, health technology assessment, and health-economic evaluation. State-transition models have been used in many different populations and diseases, and their applications range from personalized health care strategies to public health programs. Most frequently, state-transition models are used in the evaluation of risk factor interventions, screening, diagnostic procedures, treatment strategies, and disease management programs. The goal of this article was to provide consensus-based guidelines for the application of state-transition models in the context of health care. We structured the best practice recommendations in the following sections: choice of model type (cohort vs. individual-level model), model structure, model parameters, analysis, reporting, and communication. In each of these sections, we give a brief description, address the issues that are of particular relevance to the application of state-transition models, give specific examples from the literature, and provide best practice recommendations for state-transition modeling. These recommendations are directed both to modelers and to users of modeling results such as clinicians, clinical guideline developers, manufacturers, or policymakers.

ناشر
Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: Value in Health - Volume 15, Issue 6, September–October 2012, Pages 812–820
نویسندگان
, , , , , , ,